Selected article for: "drug acquisition cost and Explicit time interval"

Author: Patricia Rios; Amruta Radhakrishnan; Sonia M. Thomas; Nazia Darvesh; Sharon E. Straus; Andrea C. Tricco
Title: Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care: A rapid review of clinical practice guidelines
  • Document date: 2020_3_26
  • ID: kwncu3ji_92
    Snippet: ☐A statement that the guideline will be updated ☐Explicit time interval or explicit criteria to guide decisions about when an update will occur ☐Methodology for the updating procedure ☐Types of facilitators and barriers that were considered ☐Methods by which information regarding the facilitators and barriers to implementing recommendations were sought (e.g., feedback from key stakeholders, pilot testing of guidelines before widespread .....
    Document: ☐A statement that the guideline will be updated ☐Explicit time interval or explicit criteria to guide decisions about when an update will occur ☐Methodology for the updating procedure ☐Types of facilitators and barriers that were considered ☐Methods by which information regarding the facilitators and barriers to implementing recommendations were sought (e.g., feedback from key stakeholders, pilot testing of guidelines before widespread implementation) ☐Information/description of the types of facilitators and barriers that emerged from the inquiry (e.g., practitioners have the skills to deliver the recommended care, sufficient equipment is not available to ensure all eligible members of the population receive mammography) ☐Types of cost information that were considered (e.g., economic evaluations, drug acquisition costs)

    Search related documents:
    Co phrase search for related documents
    • cost information and drug acquisition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cost information and drug acquisition cost: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cost information and economic evaluation: 1, 2, 3, 4
    • cost information and Explicit time: 1, 2
    • cost information and Explicit time interval: 1, 2
    • cost information and mammography receive: 1, 2
    • cost information and Methodology occur: 1, 2
    • cost information and pilot testing: 1, 2
    • drug acquisition and economic evaluation: 1
    • drug acquisition and Explicit time: 1, 2
    • drug acquisition and Explicit time interval: 1, 2
    • drug acquisition and mammography receive: 1, 2
    • drug acquisition and Methodology occur: 1, 2
    • drug acquisition and pilot testing: 1, 2
    • drug acquisition cost and Explicit time: 1, 2
    • drug acquisition cost and Explicit time interval: 1, 2
    • drug acquisition cost and mammography receive: 1, 2
    • drug acquisition cost and Methodology occur: 1, 2
    • drug acquisition cost and pilot testing: 1, 2